AI assistant
Sending…
Lunai Bioworks Inc. — Director's Dealing 2019
Aug 2, 2019
34813_dirs_2019-08-01_d935cc1b-6c6e-44fc-a49c-2e3151410d92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2019-07-30
Reporting Person: Sandler Carl Forest Jr (Director, 10% Owner)
Reporting Person: William Anderson Wittekind (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-30 | Common Stock | J | 3631234 | — | Acquired | 22445397 | Indirect |
Footnotes
F1: On July 30, 2019, Weird Science, LLC received 3,631,234 shares of common stock pursuant to a contractual right to receive shares upon the exercise of warrants by warrant holders of the Issuer. Mr. Sandler and W. Anderson Wittekind are each managers of Weird Science and share investment control over the shares held by Weird Science, LLC.
More from Lunai Bioworks Inc.
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Regulatory Filings
2026
Feb 23
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2026
Feb 12